Gastric cancer-derived extracellular vesicles enriched with miR-675-3p inhibit the target gene CXXC4 and elevate PD-L1 expression through the MAPK signaling pathway, thus stimulating the immune escape and cisplatin resistance of gastric cancer cells. The gene discussed is CXXC4; the disease is gastric cancer.